Braskem S.A. (BAK) Stock Falls -22% Over 30 Days Amid Ongoing Debt Restructuring
Key Takeaways
- Braskem S.A. (BAK) has fallen about 22% over the past 30 days, from a $2.67 close on July 14, 2026, to the latest available price near $2.08 in mid-August.
- The decline reflects unresolved debt-restructuring negotiations, creditor rejection of the company's initial proposal, and a June court-protection filing that led S&P Global Ratings to cut Braskem to 'D'.
- Weak petrochemical spreads, polyethylene and polypropylene oversupply, and financial stress at the Braskem Idesa unit in Mexico continue to weigh on sentiment.
- Analyst conviction has deteriorated, with several downgrades in June and July pushing consensus toward a sell/underperform view.
- Over the trailing three months, the stock has lost roughly 58% from its May 13, 2026 close of $4.97 after touching a 52-week high.
Braskem S.A. (BAK) Company Overview and Market Position
Braskem S.A. is a Brazilian integrated petrochemical company and the largest producer of thermoplastic resins in the Americas. Its portfolio centers on polyethylene, polypropylene, and PVC, along with basic petrochemical feedstocks such as ethylene and propylene, serving packaging, automotive, construction, and consumer-goods markets. The company operates through three main segments—Brazil, the United States and Europe, and Mexico—and its American depositary shares trade on the NYSE under the BAK symbol. Following the 2026 transfer of control to IG4 Capital, with Petrobras remaining a key shareholder, investors track Braskem for exposure to the global petrochemical cycle, Brazilian industrial demand, and the company's capital-structure turnaround.
Braskem S.A. (BAK) Stock Price Performance: Last 30 Days vs. Quarter
Braskem's latest available price of $2.075 (intraday, Aug. 13, 2026) compares with the July 14, 2026 close of $2.67, producing a 30-day decline of approximately 22.3%. Within that window, selling was persistent but not uniform: the stock dropped from the $2.67 area in mid-July to a $2.04 close on Aug. 12, with the Aug. 12 session marking the sharpest single-day move at -7.7%. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The picture is steeper over the trailing quarter. Braskem closed at $4.97 on May 13, 2026, after setting a 52-week high of $5.395 that same month. From that level, the decline to roughly $2.08 represents a loss of about 58%. The move illustrates how a brief first-quarter earnings-related advance gave way to a restructuring-driven repricing.
What Drove BAK Stock Price in the Last 30 Days
Capital-structure risk has been the dominant driver. On Aug. 12, Reuters reported that Braskem was in advanced discussions to file for out-of-court restructuring that could be submitted within August, covering more than $10 billion of debt across Brazil, the United States, and Europe; the report also noted possible parallel restructuring options for roughly $2 billion of debt at the Braskem Idesa subsidiary in Mexico. BAK shares fell 7.7% that day to $2.04.
The 30-day decline extends a restructuring-driven selloff that began in late June, when the company filed for mediation and precautionary injunctive relief after creditors rejected its initial proposal. S&P Global Ratings downgraded Braskem to 'D' from 'CCC-' on June 26, treating the court-ordered standstill as equivalent to a payment default. The protection period was subsequently reported to run through late August, leaving investors focused on whether a creditor agreement can be reached.
Analyst actions compounded the pressure. Weiss Ratings reiterated a sell-style rating in mid-July, and by late July MarketBeat data showed a consensus "Strong Sell" rating with an average price target around $3.40. With shares trading well below their 50-day and 200-day moving averages, technical selling also contributed.
What Drove BAK Stock Performance Over the Last Quarter
Over the trailing three months, Braskem shares moved from a May peak near $5.40 to the low-$2 range. The first-quarter report released on May 14 showed a sharp sequential improvement in recurring EBITDA, helped by higher spreads and operational recovery, and the stock rallied into the release. The advance proved short-lived as the broader petrochemical downcycle reasserted itself: compressed spreads, oversupply in polyethylene and polypropylene, weak demand, and liquidity strain at Braskem Idesa all returned to the foreground.
Governance and balance-sheet developments added to the pressure. A June 8 shareholder meeting approved broad bylaw changes and installed new leadership, including CEO Helcio Tokeshi. Weeks later, the company's mediation filing and the S&P downgrade to 'D' crystallized creditor concerns. Braskem's substantial Alagoas remediation liabilities and heavy near-term debt-service obligations reinforced the negative narrative, and the absence of a creditor agreement by mid-August kept the stock under sustained pressure.
BAK Stock Forecast Drivers: What Investors Should Watch Next
The restructuring timeline is the central near-term variable, including whether Braskem files for out-of-court recovery, reaches a creditor agreement, or pursues alternatives for its Brazil, U.S., and Europe debt and for Braskem Idesa. Investors should also monitor second-quarter results for EBITDA trends, cash position, leverage, and any formal guidance. Industry fundamentals matter as well: polyethylene and polypropylene spreads, resin pricing and demand, global capacity dynamics, and import conditions in Brazil. Alagoas remediation progress, analyst estimate revisions, and Brazilian currency and interest-rate conditions round out the key watchpoints. These factors carry meaningful uncertainty, and they are informational rather than a basis for investment decisions. From what I see, monitoring these elements closely remains essential given the current environment.
Using Tickeron AI Tools for Additional Perspective
In my research on names facing significant volatility, I often turn to Tickeron’s AI Trading Bots to review automated strategies that provide a range of signals across different timeframes and market conditions. These tools add a layer of data-driven insight that complements fundamental analysis without replacing it.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
BAK in upward trend: price may jump up because it broke its lower Bollinger Band on August 12, 2026
BAK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 45 cases where BAK's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator entered the oversold zone -- be on the watch for BAK's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for BAK just turned positive on July 09, 2026. Looking at past instances where BAK's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BAK advanced for three days, in of 255 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on July 31, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BAK as a result. In of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The 50-day moving average for BAK moved below the 200-day moving average on July 27, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BAK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for BAK entered a downward trend on August 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BAK's P/B Ratio (142.857) is very high in comparison to the industry average of (9.176). BAK has a moderately low P/E Ratio (0.000) as compared to the industry average of (30.298). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (20.317). BAK has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.037). P/S Ratio (0.062) is also within normal values, averaging (1.443).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BAK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BAK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of petrochemicals and other related products
Industry ChemicalsMajorDiversified
Advertisement